Stocks
Bristol-Myers (BMY) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 735.4% | 1 480% | 1 048% | 850.5% | 769.1% | 820.2% | |||
| Changes by years, y/y, % | +68pp | +744pp | -432pp | -197pp | -81pp | +2.9% | |||
Bristol-Myers. R&D/CAPEX, %
Bristol-Myers. R&D/CAPEX, changes, pp
Bristol-Myers (BMY) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 655.6% | 750.9% | 948.9% | 876.0% | 732.7% | 820.2% | ||
| Changes by years, y/y, % | -323pp | +25pp | +114pp | +4pp | +77pp | |||
| Changes by quarters, q/q, % | -216pp | +95pp | +198pp | -73pp | -143pp | |||
